Profound Medical (NASDAQ: PROF; TSX: PRN) has seen the first MRI-guided prostate cancer treatment performed using its TULSA-PRO system at the Mātai Medical Research Institute in Gisborne, New Zealand, following its...
Lucid Diagnostics (NASDAQ: LUCD), a subsidiary of PAVmed (Nasdaq: PAVM), has announced a peer-reviewed publication of findings from the largest real-world clinical experience of nonendoscopic esophageal precancer...
Pasithea Therapeutics (NASDAQ: KTTA) has announced that the FDA has cleared its Investigational New Drug (IND) application for a randomized, placebo-controlled Phase 2 clinical trial for PAS-004 in patients with NF1...
Ernexa Therapeutics (NASDAQ: ERNA) is developing engineered cell therapies designed to modulate the immune system and address significant unmet needs in cancer and autoimmune disease. The company aims to advance its...
Closely held Specific Biologics has announced the closing of an oversubscribed $35 million Series A financing. The round was led by Hatteras Venture Partners, with participation from foundational investors Lumira...
HeartBeam (NASDAQ: BEAT) has revealed positive results today from its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack assessment presented by Graham Nichol, MD, MPH, FRCP(C), of the University of...
NeuroSense Therapeutics (NASDAQ: NRSN) has announced plans to incorporate newly generated data into its New Drug Submission (NDS) to Health Canada for PrimeC, its lead investigational therapy for amyotrophic lateral...
Allarity Therapeutics (NASDAQ: ALLR) has announced its first revenue-generating contract under its newly established Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory services strategy, which is...
Profound Medical (NASDAQ: PROF; TSX: PRN) has announced that it has entered into a supply and distribution agreement with the iMRI Division of closely held Cook Medical to expand U.S. sales of its TULSA-PRO system...
Perimeter Medical Imaging AI’s (TSX-V: PINK; OTCQX: PYNKF) Claire OCT has received a special mention in TIME’s Best Inventions of 2026, earning national recognition for its approach to helping surgeons identify...